
F13B Antilichaam - middengebied: Biotine (ARP41999 P050-Biotine)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Coagulation factor XIII, B polypeptide
FXIIIB
2165
P05160
NP_001985
• Rabbit
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit
The immunogen is a synthetic peptide directed towards the middle region of human F13B
F13B contains 10 Sushi (CCP/SCR) domains. The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. Defects in F13B can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
FGG; F13A1
• Polyclonal
Biotin
Polyclonal Antibody
WB
Affinity Purified
0.5 mg/ml
Cow: 100%; Dog: 86%; Guinea Pig: 100%; Horse: 93%; Human: 100%; Mouse: 100%; Rabbit: 93%; Rat: 100%
Liquid. Purified antibody supplied in 1x PBS buffer.
All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.
73kDa
Pruissen, D.M., (2008) Blood 111 (3), 1282-1286
Wet Ice
661
F13B
F13B
Rabbit
Coagulation factor XIII B chain
NM_001994
LRLIENGYFHPVKQTYEEGDVVQFFCHENYYLSGSDLIQCYNFGWYPESP
Beschrijving
F13B Antilichaam - middengebied: Biotine (ARP41999 P050-Biotine) Beschikbaar in 100 µL. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten

MARV VP40/Marburg VP40 Protein (N-His, Lake Victoria marburgvirus (strain Musoke-80) (MARV) (Marburg virus (strain Kenya/Musoke/1980) ) )
P505862
100 µg

Drug Stability Chamber
500-DSC102
1 Unit

Modular Incubator Chamber
MIC-101
1 Unit

CYP707A2 Antibody
GTR17947107
2 mg

SsDNA Assay Kit
12645ES60
100 Tests

Eco Alu MTP (HxD) 6x7=42 plates 35mm, 223x630x135mm
TE15336
1 Piece

Arachis hypogaea Lectin (PNA) - Biotinylated
21510020-1
5mg

Cellubrevin Antibody
MBS9436639-01
0.05 mL
Recent gezochte producten

MARV VP40/Marburg VP40 Protein (N-His, Lake Victoria marburgvirus (strain Musoke-80) (MARV) (Marburg virus (strain Kenya/Musoke/1980) ) )
P505862
100 µg

BDBV Nucleoprotein Recombinant Protein (N-His)
VK059012-01
50 µg

KBFP720 700L Stability Chamber
CHA3020
1 Each

KBFLQC240 247L Stability Chamber
CHA3022
1 Each

KBF1020 1020L Stability Chamber
CHA3024
1 Each

Stability Chamber KBFP240 247L
CHA3030
1 Each

Drug Stability Chamber
150-DSC100
1 Unit

Drug Stability Chamber
150-DSC200
1 Unit
